» Articles » PMID: 23652017

The Gut Microbiota Suppresses Insulin-mediated Fat Accumulation Via the Short-chain Fatty Acid Receptor GPR43

Overview
Journal Nat Commun
Specialty Biology
Date 2013 May 9
PMID 23652017
Citations 629
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota affects nutrient acquisition and energy regulation of the host, and can influence the development of obesity, insulin resistance, and diabetes. During feeding, gut microbes produce short-chain fatty acids, which are important energy sources for the host. Here we show that the short-chain fatty acid receptor GPR43 links the metabolic activity of the gut microbiota with host body energy homoeostasis. We demonstrate that GPR43-deficient mice are obese on a normal diet, whereas mice overexpressing GPR43 specifically in adipose tissue remain lean even when fed a high-fat diet. Raised under germ-free conditions or after treatment with antibiotics, both types of mice have a normal phenotype. We further show that short-chain fatty acid-mediated activation of GPR43 suppresses insulin signalling in adipocytes, which inhibits fat accumulation in adipose tissue and promotes the metabolism of unincorporated lipids and glucose in other tissues. These findings establish GPR43 as a sensor for excessive dietary energy, thereby controlling body energy utilization while maintaining metabolic homoeostasis.

Citing Articles

Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control.

Jiang Z, He L, Li D, Zhuo L, Chen L, Shi R Nat Metab. 2025; .

PMID: 40087408 DOI: 10.1038/s42255-025-01246-5.


Cardiac energy metabolic disorder and gut microbiota imbalance: a study on the therapeutic potential of Shenfu Injection in rats with heart failure.

Zhao Z, Hu Z, Li L Front Microbiol. 2025; 16:1509548.

PMID: 40071211 PMC: 11895768. DOI: 10.3389/fmicb.2025.1509548.


Impact of Short-Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes.

Tingstad R, Witczak O, Beajani S, Seo S, Lovsletten N, Skagen C Endocrinol Diabetes Metab. 2025; 8(2):e70042.

PMID: 40051343 PMC: 11885951. DOI: 10.1002/edm2.70042.


Gut-X axis.

Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J Imeta. 2025; 4(1):e270.

PMID: 40027477 PMC: 11865426. DOI: 10.1002/imt2.270.


The relationship between dietary index for gut microbiota and diabetes.

Wu Z, Gong C, Wang B Sci Rep. 2025; 15(1):6234.

PMID: 39979448 PMC: 11842723. DOI: 10.1038/s41598-025-90854-y.


References
1.
Vijay-Kumar M, Aitken J, Carvalho F, Cullender T, Mwangi S, Srinivasan S . Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328(5975):228-31. PMC: 4714868. DOI: 10.1126/science.1179721. View

2.
Bjursell M, Admyre T, Goransson M, Marley A, Smith D, Oscarsson J . Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab. 2010; 300(1):E211-20. DOI: 10.1152/ajpendo.00229.2010. View

3.
Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F . G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009; 183(11):7514-22. DOI: 10.4049/jimmunol.0900063. View

4.
Rains J, Jain S . Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2010; 50(5):567-75. PMC: 3557825. DOI: 10.1016/j.freeradbiomed.2010.12.006. View

5.
Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J . Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol. 2008; 74(6):1599-609. DOI: 10.1124/mol.108.049536. View